Everything on Operational Realities

Physical constraints in drug development, including multi-year clinical timelines, prevent AI from fully automating discovery, preserving the need for domain expertise.

Impact: Ensures human-led diligence and capital efficiency remain critical differentiators despite rapid technological advancement.

— from Leveraging Permanent Capital & AI in Biotech Investing · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Jul 18, 2026